Cord Blood ForumKeep current on the latest updates on the Symposium, as well as other Cord Blood Transplantation information. Subscribe to the FREE Cord Blood Forum Newsletter! Use the online subscription form on the Forum website. Learn More...

Share |

Contributors


Contributions in the form of unrestricted educational grants have been graciously provided by:

NMDP

National Marrow Donor Program

3001 Broadway Street NE
Minneapolis, MN 55413-1753
1-800-MARROW2 (1-800-627-7692)
1.612.627.5800
www.marrow.org/md

The National Marrow Donor ProgramĀ® (NMDP) helps people who need a life-saving hematopoietic cell transplant. We connect patients, doctors, donors and researchers to the resources they need to help more people live longer and healthier lives. The Center for Cord Blood brings specialized resources and expertise to cord blood, providing centers with an efficient, reliable process for locating and obtaining cord blood units.

StemCyte

StemCyte International Cord Blood Center

1589 W. Industrial Park Street
Covina, CA 91722-3416 USA
1-866-783-6298
1.626.646.2500
www.stemcyte.com

StemCyte is the global leader in cord blood stem cell therapeutics. We offer public and private banking to our clients and are one of the few cord blood banks who does not use red cell reduction for our processing methods. We have released over 1200 cord blood collections for transplant to over 200 facilities world wide which is more than all other family banks combined.

Tarix

Tarix Pharmaceuticals

Richard Franklin
President & CEO
rlf629@gmail.com
www.tarixpharma.com

Tarix Pharmaceuticals is focused on unmet needs in Oncology, HIV, and other indications. Tarix's lead compound, TXA127, is currently in a Phase II clinical trial for the treatment and prevention of thrombocytopenia associated with cancer chemotherapy, a Phase II trial to enhance engraftment in patients receiving a peripheral blood stem cell engraftment, and a Phase I clinical trial to increase the CD4 counts in AIDS patients maintained on multi-drug therapy (HAART). Tarix will shortly begin two clinical trials to enhance engraftment in patients receiving a cord blood transplant.

With an additional grant from the Health Resources and Services Administration (HRSA) *

* The 8th Annual International Umbilical Cord Blood Bank Transplantation Symposium is partially financially funded by a contract between the Health Resources and Services Administration, U.S. Department and Health and Human Services, and the Cord Blood Forum. Any opinions, findings, conclusions or recommendations expressed or presented at this conference are those of the presenters and do not necessarily reflect the views of the U.S. Government, nor does mention of trade names, commercial practices or organizations imply endorsement by the U.S. Government.